243
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Leu72Met Polymorphism in Ghrelin Gene: A Potential Risk Factor for Hypertension in Type 2 Diabetes Patients

, &
Pages 557-564 | Received 21 Oct 2022, Accepted 09 Feb 2023, Published online: 01 Mar 2023

References

  • American Diabetes Association. Standards of medical care in diabetes - 2019 abridged for primary care providers. Clin Diabetes. 2019;37:11–34. doi:10.2337/cd18-0105
  • Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14:88–98. doi:10.1038/nrendo.2017.151
  • O’Rahilly S, Barroso I, Wareham NJ. Genetic factors in type 2 diabetes: the end or the beginning? Science. 2005;307:370–373. doi:10.1126/science.1104346
  • Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone releasing acylated peptide from stomach. Nature. 1999;402:656–660. doi:10.1038/45230
  • Chen CY, Asakawa A, Fujimiya M, Lee SD, Inui A. Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol Rev. 2009;61:430–481. doi:10.1124/pr.109.001958
  • Kojima M, Kanagawa K. Ghrelin: structure and function. Physiol Rev. 2005;85:495–522. doi:10.1152/physrev.00012.2004
  • Pöykkö S, Ukkola O, Kauma H, Savolainem MJ, Kesaniemi YA. Ghrelin Arg51Gln mutation is a risk factor for type 2 diabetes and hypertension in a random sample of middle-aged subjects. Diabetologia. 2003;46:455–458. doi:10.1007/s00125-003-1058-z
  • Al Qarni AA, Joatar FE, Das N, et al. Association of plasma ghrelin levels with insulin resistance in type 2 diabetes mellitus among Saudi subjects. Endocrinol Metab. 2017;32:230–240. doi:10.3803/EnM.2017.32.2.230
  • Poher AL, Tschöp MH, Müller TD. Ghrelin regulation of glucose metabolism. Peptides. 2018;100:236–242. doi:10.1016/j.peptides.2017.12.015
  • Ghalandari H, Hosseini-Esfahani F, Mirmiran P. The association of polymorphisms in leptin / leptin receptor gene and ghrelin / ghrelin receptor gene with overweight / obesity and the related metabolic disturbances: a review. Int J Endocrinol Metab. 2015;13:e19073. doi:10.5812/ijem.19073v2
  • Zang P, Yang CH, Liu J, et al. Relationship between acyl and desacyl ghrelin levels with insulin resistance and body fat mass in type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2022;15:2763–2770. doi:10.2147/DMSO.S368770
  • Kanamoto N, Akamizu T, Tagami T, et al. Genomic structure and characterization of the 5’ flanking region of the human ghrelin gene. Endocrinology. 2004;145:4144–4153. doi:10.1210/en.2003-1718
  • Liao N, Xie Z-K, Huang J, Xie Z-F. Association between the ghrelin Leu72Met polymorphism and type 2 diabetes risk: a meta-analysis. Gene. 2013;517:179–183. doi:10.1016/j.gene.2012.12.094
  • Xu LL, Xiang HD, Qiu CC, Xsu Q. Association of ghrelin polymorphisms with metabolic syndrome in Han nationality Chinese. Biomed Environ Sci. 2008;21:188–192. doi:10.1016/S0895-3988(08)60027-6
  • Zavarella S, Petrone A, Zampetti S, et al. A new variation in a promoter region, the −604 C>T, and the Leu72Met polymorphism of the ghrelin gene are associated with protection to insulin resistance. Int J Obes. 2008;32:663–668. doi:10.1038/sj.ijo.0803766
  • Vitolo E, Santini E, Seghieri M, et al. Heterozygosity for the rs696217 in the preproghrelin gene predicts weight loss after bariatric surgery in severe obese individuals. Obes Surg. 2017;27:961–967. doi:10.1007/s11695-016-2387-6
  • Buraczynska M, Gwiazda-Tyndel K, Drop B, Zaluska W. Renalase gene Glu37Asp polymorphism affects susceptibility to diabetic retinopathy in type 2 diabetes mellitus. Acta Diabetol. 2021;58:1596–1602. doi:10.1007/s00592-021-01740-8
  • Madisen L, Hoar DI, Helroyd CD, Crisp H, Hodes ME. DNA banking: the effect of storage of blood and isolated DNA on the integrity of DNA. American Journal of Medical Genetics. 1987;27:379–390. doi:10.1002/ajmg.1320270216
  • Hansson C, Annerbrink K, Nilsson S, et al. A possible association between panic disorder and the polymorphism in the preproghrelin gene. Psychiatry Res. 2013;206:22–25. doi:10.1016/j.psychres.2012.09.051
  • Fuchsberger C, Funnick J, Teslovich TM, et al. The genetic architecture of type 2 diabetes. Nature. 2016;536:41–47. doi:10.1038/nature18642
  • Li Y, Lu X, Yang X, et al. GHRL gene Leu72Met polymorphism and type 2 diabetes mellitus: a meta-analysis involving 8194 participants. Front Endocrinol. 2019;10:article559. doi:10.3369/endo.2019.00559
  • Mager U, Lindt V, Lindström J, et al. Association of the Leu72Met polymorphism of the ghrelin gene with the risk of type 2 diabetes in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study. Diabetic Med. 2006;23:685–689. doi:10.1111/j.1464-5491.2006.01870.x
  • Zhuang L, Li M. Yu et al. The Leu72Met polymorphism of the GHRL gene prevents the development of diabetic nephropathy in Chinese patients with type 2 diabetes mellitus. Mol Cell Biochem. 2014;387:19–25. doi:10.1007/s11010-013-1865-6
  • Rivera-Leon EA, Llamas-Covarrubias MA, Sanchez-Enriquez S, et al. Leu72Met polymorphism of GHRL gene decreases susceptibility to type 2 diabetes mellitus in a Mexican population. BMC Endocrinol Dis. 2020;20:109. doi:10.1186/s12902-020-00596-3
  • Takezawa J, Yamada K, Morita A, Alba N, Watanabe S. Preproghrelin gene polymorphisms in obese Japanese: association with diabetes mellitus in men and with metabolic syndrome parameters in women. Obesity Res Clin Pract. 2009;3:179–191. doi:10.1016/j.orcp.2009.04.003
  • Larsen LH, Gjesing AP, Sorensen TA, et al. Mutation analysis of the preproghrelin gene: no association with obesity and type 2 diabetes. Clin Biochem. 2005;38:420–424. doi:10.1016/j.clinbiochem.2005.01.008
  • Kim SY, Jo DS, Hwang PH, Park SK, Yi HK, Lee DY. Preproghrelin Leu72Met polymorphism is not associated with type 2 diabetes mellitus. Metabolism. 2006;55:366–370. doi:10.1016/j.metabol.2005.09.011
  • Garcia EA, King P, Sidhu K, et al. The role of ghrelin and ghrelin-receptor gene variants and promoter activity in type 2 diabetes. Eur J Endocrinol. 2009;161:307–315. doi:10.1530/EJE-09-0122
  • Hedayatizadeh-Omran A, Rafei A, Khajavi R, Alizadeh Navaei R, Mokhberi V, Moradzadeh K. Association between ghrelin gene (Leu72Met) polymorphism and ghrelin serum level with coronary artery disease. DNA Cell Biol. 2014;33. doi:10.1089/dna2013.2218
  • Joatar FE, AlQarni AA, Ali ME, et al. Leu72Met and other intronic polymorphisms in the GHRL and GHDR genes are not associated with type 2 diabetes mellitus, insulin resistance, or serum ghrelin levels in a Saudi population. Endocrinol Metab. 2017;32:360–369. doi:10.3803/EnM.2017.32.3.360
  • Liu J, Liu J, Tian L, et al. Association of ghrelin Leu72Met polymorphism with type 2 diabetes mellitus in Chinese population. Gene. 2012;504:309–312. doi:10.1016/j.gene.2012.03.025
  • Nagaya N, Kojima M, Uematsu M, et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1483–R1487. doi:10.1152/ajpregu.2001.280.5.R1483
  • Pöykkö SM, Kellokoski E, Hörkkö S, Kauma H, Kesäniemi YA, Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension and the prevalence of type 2 diabetes. Diabetes. 2003;52:2546–2553. doi:10.2337/diabetes.52.10.2546
  • Berthold HK, Giannakidou E, Krone W, Gouni-Berthold I. Influence of ghrelin gene polymorphism on hypertension and atherosclerotic disease. Hypertens Res. 2010;33:155–160. doi:10.1038/hr.2009.194
  • Ukkola O, Ravussin E, Jacobson P, et al. Role of ghrelin polymorphisms in obesity based on three different studies. Obes Res. 2002;10:782–791. doi:10.1038/oby.2002.106
  • Mager U, Kolehmainen M, Lindström J, et al. Association between ghrelin gene variations and blood pressure in subjects with impaired glucose tolerance. Am J Hypertens. 2006;19:920–926. doi:10.1016/j.amjhyper.2006.02.017
  • Ukkola O. Genetic variants of ghrelin in metabolic disorders. Peptides. 2011;32:2319–2322. doi:10.1016/j.peptides.2011.04.013